| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23622899a40ed163cd5bf570d6baf2a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-912 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
| filingDate |
2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17282496b53e915464ee6f6fa5b3b253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ea4fa160773c9eb9d11f6ef11dc7527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb742306edd4404453649d47f8b5e3ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff74a397a2cd617a060241a931a0fbc |
| publicationDate |
2017-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017319527-A1 |
| titleOfInvention |
Carbidopa for the Treatment of Cancer |
| abstract |
The present invention includes a method of inhibiting or reducing mTOR signaling or inhibition of indoleamine dioxygenase-1 (IDO1) in a subject with a proliferative disease, which comprises administering to the subject having or suspected to have the proliferative disease, a therapeutically or prophylactically effective amount of the compound of Formula I: n n n n n n n n n n or a pharmaceutically acceptable salt or solvate thereof. |
| priorityDate |
2016-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |